Tak Yee Tania Tai

Dr. Tak Yee Tania Tai

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2018 in Asia-Pacific Journal of Ophthalmology
Verified
Journal Article
Open access
TTTak Yee Tania Tai
Tak Yee Tania Tai
The Asia-Pacific Journal of Ophthalmology (APJO) is the official publication of the Asia-Pacific Academy of Ophthalmology. The APJO positions itself as a first-class bimonthly (6 issues per year) peer-viewed e-journal representative of ophthalmic and visual science developments in the Asia-Pacific region. The APJO welcomes the submission of original, previously unpublished manuscripts which describe clinical investigations, clinical observations and clinically relevant laboratory investigations.

6 September 2025 in Diagnostics
Verified
Journal Article
Open access
PDF file
AVAlice Verticchio Vercellin
Alice Verticchio Vercellin
LILauren Isserow
Lauren Isserow
Richard RosenRichard Rosen
Richard Rosen
PSPaul A. Sidoti
Paul A. Sidoti
Brent SieskyBrent Siesky
Brent Siesky
GAGal Antman
Gal Antman
Purpose: We aimed to analyze the effects of age on human tear film (TF) using a novel nanometer resolution TF imaging device (Tear Film Imager, TFI, AdOM, Israel). Methods: 44 healthy adult subjects (≥18 years of age) without ocular or systemic diseases or prior eye treatments with ages spanning seven decades were enrolled in this prospective cross-sectional study. Subjects underwent a comprehensive ophthalmic examination and completed the Ocular Surface Disease Index questionnaire (OSDI). All study participants underwent TF imaging using the TFI, including assessment of muco-aqueous layer thickness (MALT), lipid-layer thickness (LLT), inter-blink interval, and lipid map uniformity. Associations between TFI parameters and age were tested using linear regression (accounting for multiple eyes). Results: A total of 80 eyes (44 subjects) were imaged: 19 eyes from 10 subjects in the 3rd decade of life (aged 20–29); 10 eyes from 5 subjects in the 4th decade of life (aged 30–39); 5 eyes from 3 subjects in the 5th decade of life (40–49); 12 eyes from 7 subjects in the 6th decade of life (50–59), 19 eyes from 11 subjects in the 7th decade of life (60–69); 11 eyes from 6 subjects in the 8th decade of life (70–79); and 4 eyes from 2 subjects in the 9th decade of life (80–89). With increasing age, MALT significantly decreased (p = 0.024), and LLT significantly increased (p = 0.001). No statistically significant linear age effects were found for the other TFI parameters (p > 0.05) or the OSDI scores of study participants of different ages (p = 0.786). Conclusions: Quantitative TF biomarkers varied significantly with advancing age in healthy individuals, highlighting the importance of accounting for age in TF assessments.

16 November 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
ALAng Li
Ang Li
WSW. Daniel Stamer
W. Daniel Stamer
TTTak Yee Tania Tai
Tak Yee Tania Tai
SSSandra Sieminski
Sandra Sieminski
LHLeon W. Herndon
Leon W. Herndon
TITsontcho Ianchulev
Tsontcho Ianchulev
Surgery of Schlemm’s canal has evolved over two decades from bleb-dependent, ab-externo viscocanalostomy into a family of tissue-sparing, ab-interno, and scaffold-reinforced procedures. We trace five generations of canal surgery and evaluate whether durable structural reinforcement of the restored canal, with preservation of the trabecular meshwork, determines long-term outcome. Imaging and histology show that the glaucomatous canal is narrowed and partially collapsed, with canal area inversely related to intraocular pressure. Viscoelastic injected into the canal is cleared within 24 hours, whereas a tensioning suture sustains canal expansion beyond 20 months and outperforms viscocanalostomy, particularly at stringent pressure targets. Ab-interno canaloplasty sustains pressure and medication reduction for 3 to 6 years but leaves no structural element in the canal. A nitinol intracanalicular scaffold has 5-year randomized evidence of benefit but provokes persistent angle reactivity, with cumulative peripheral anterior synechiae of 14.6% versus 3.7% after cataract surgery alone. Acellular scleral allograft is safe and non-migrating as a uveoscleral cleft scaffold but has not been studied inside Schlemm’s canal. Biologic intracanalicular reinforcement is a coherent but untested next step that requires randomized, morphometric evaluation.

1 May 2024 in The Pan-American Journal of Ophthalmology
Verified
Journal Article
Closed access
BBBryana Banashefski
Bryana Banashefski
PSPaul A. Sidoti
Paul A. Sidoti
TTTak Yee Tania Tai
Tak Yee Tania Tai
Tube occlusion with elevation of the intraocular pressure (IOP) is a well-described complication of glaucoma drainage implant (GDI) surgery. Most commonly, obstruction occurs at the proximal tube tip from iris, vitreous, or blood. Further intervention is often required to remove the obstruction and reestablish aqueous outflow. Herein, we describe a patient in whom obstruction of the distal tube ostium by clotted blood from a spontaneous hemorrhage into the endplate capsule of an Ahmed Glaucoma Valve (AGV) resulted in severe IOP elevation. This is the first report in the literature of distal tube occlusion by blood from a spontaneous hemorrhage into the endplate capsule of a GDI. Prompt recognition of this entity is important for appropriate treatment planning and patient counselling.